全文获取类型
收费全文 | 110182篇 |
免费 | 9964篇 |
国内免费 | 6543篇 |
专业分类
耳鼻咽喉 | 1399篇 |
儿科学 | 1314篇 |
妇产科学 | 1095篇 |
基础医学 | 13776篇 |
口腔科学 | 1905篇 |
临床医学 | 13153篇 |
内科学 | 18123篇 |
皮肤病学 | 1510篇 |
神经病学 | 6279篇 |
特种医学 | 5309篇 |
外国民族医学 | 37篇 |
外科学 | 11965篇 |
综合类 | 14958篇 |
现状与发展 | 26篇 |
一般理论 | 12篇 |
预防医学 | 6672篇 |
眼科学 | 2648篇 |
药学 | 11385篇 |
89篇 | |
中国医学 | 5252篇 |
肿瘤学 | 9782篇 |
出版年
2024年 | 322篇 |
2023年 | 1598篇 |
2022年 | 4074篇 |
2021年 | 5638篇 |
2020年 | 4093篇 |
2019年 | 3738篇 |
2018年 | 3878篇 |
2017年 | 3506篇 |
2016年 | 3620篇 |
2015年 | 5262篇 |
2014年 | 6199篇 |
2013年 | 6067篇 |
2012年 | 8711篇 |
2011年 | 9251篇 |
2010年 | 6227篇 |
2009年 | 4887篇 |
2008年 | 6121篇 |
2007年 | 6095篇 |
2006年 | 5549篇 |
2005年 | 5316篇 |
2004年 | 3902篇 |
2003年 | 3822篇 |
2002年 | 3234篇 |
2001年 | 2433篇 |
2000年 | 2126篇 |
1999年 | 2094篇 |
1998年 | 1194篇 |
1997年 | 1155篇 |
1996年 | 840篇 |
1995年 | 850篇 |
1994年 | 685篇 |
1993年 | 406篇 |
1992年 | 643篇 |
1991年 | 478篇 |
1990年 | 441篇 |
1989年 | 416篇 |
1988年 | 337篇 |
1987年 | 316篇 |
1986年 | 277篇 |
1985年 | 182篇 |
1984年 | 120篇 |
1983年 | 88篇 |
1982年 | 51篇 |
1981年 | 51篇 |
1980年 | 37篇 |
1979年 | 51篇 |
1977年 | 30篇 |
1976年 | 38篇 |
1974年 | 33篇 |
1973年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
目的 探讨膝骨美节炎(KOA)患者美节滑液中IL 17的水平与疾病严重程度的相关性,为临床诊治KOA 提供新思路及新方法。方法 选取2017年1月?2018年12月南充市中心医院康复科收治的15。例膝骨美节炎患者作 为实验组,同时纳入30例健康志愿者作为对照组。实验组釆用视觉模拟量表(VAS)评价膝关节的疼痛程度,采用膝关 节学会评分系统(KSS)评价膝关节的功能及采用Kellgren Lawrence (KL)分级系统评价膝关节X线严重程度,通过 ELISA试验检测两组膝关节滑液中IL17的水平。采用Spearman相关分析KOA患者关节滑液中IL 17水平与膝关节 疼痛程度、膝关节功能及X线严重程度的相关性。结果 实验组关节滑液中IL17的水平明显高于对照组(P <0. 05). IL 17水平在滕美节炎KL分级之间比较,差异无统计学差异(P>0. 05)。IL 17的水平与膝关节VAS评分呈正相关 (P=0. 914,P<0.01),IL 17的水平与KSS呈负相关(P=—0. 847,P<0. 01), IL 17的水平与KL分级无相关性(r = 0.050,P= 0.545)。结论 IL 17可反应膝骨关节炎患者疼痛程度及功能损伤程度,但不能反映疾病的X线严重程度。 IL 17可作为一个生化指标反应膝关节炎疼痛程度及膝关节功能,临床通过减少关节滑液中IL 17,可能会减轻膝骨关 节炎患者的临床症状。 相似文献
32.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
33.
34.
Learning to Discretize: Solving 1D Scalar Conservation Laws via Deep Reinforcement Learning 下载免费PDF全文
Yufei Wang Ziju Shen Zichao Long & Bin Dong 《Communications In Computational Physics》2020,28(5):2158-2179
Conservation laws are considered to be fundamental laws of nature. It has
broad applications in many fields, including physics, chemistry, biology, geology, and
engineering. Solving the differential equations associated with conservation laws is a
major branch in computational mathematics. The recent success of machine learning,
especially deep learning in areas such as computer vision and natural language processing, has attracted a lot of attention from the community of computational mathematics and inspired many intriguing works in combining machine learning with traditional methods. In this paper, we are the first to view numerical PDE solvers as an
MDP and to use (deep) RL to learn new solvers. As proof of concept, we focus on
1-dimensional scalar conservation laws. We deploy the machinery of deep reinforcement learning to train a policy network that can decide on how the numerical solutions should be approximated in a sequential and spatial-temporal adaptive manner.
We will show that the problem of solving conservation laws can be naturally viewed
as a sequential decision-making process, and the numerical schemes learned in such a
way can easily enforce long-term accuracy. Furthermore, the learned policy network
is carefully designed to determine a good local discrete approximation based on the
current state of the solution, which essentially makes the proposed method a meta-learning approach. In other words, the proposed method is capable of learning how to
discretize for a given situation mimicking human experts. Finally, we will provide details on how the policy network is trained, how well it performs compared with some
state-of-the-art numerical solvers such as WENO schemes, and supervised learning
based approach L3D and PINN, and how well it generalizes. 相似文献
35.
Wen Wang Yanmei Liu Chuan Yu Jing Tan Weiyi Xiong Duo Dong 《Expert opinion on drug safety》2020,19(3):339-347
ABSTRACTObjectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding.Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with cefoperazone-tazobactam or ceftazidime. Propensity-score matching was used to explore whether treatment with cefoperazone-sulbactam increased the risk of prothrombin time (PT) prolongation, coagulation disorders, and bleeding, or decreased platelets (PLT).Results: The cohort included 23,242 patients. Among patients receiving cefoperazone-sulbactam, the risk of PT prolongation, coagulation disorders, decreased PLT, and bleeding was 5.3%, 9.2%, 15.7%, and 4.2%, respectively. Propensity-score matching analyses suggested that cefoperazone-sulbactam increased the risk of PT prolongation (aOR 2.26, 95% CI 1.61–3.18), coagulation disorders (aOR 1.81, 95% CI 1.43–2.30), and decreased PLT (aOR 1.46, 95% CI 1.25–1.72), but not increase bleeding (aOR 1.05, 95% CI 0.79–1.40) compared with ceftazidime. Patients receiving cefoperazone-sulbactam had higher risk of PT prolongation (aOR 1.53, 95% CI 1.11–2.10), coagulation disorders (aOR 1.53, 95% CI 1.21–1.95), but not decreased PLT (aOR 0.93, 95% CI 0.81–1.07) or bleeding (aOR 1.11, 95% CI 0.87–1.42), compared with those receiving cefoperazone-tazobactam.Conclusion: Cefoperazone-sulbactam may be associated with a higher risk of PT prolongation and coagulation disorders compared with cefoperazone-tazobactam and ceftazidime. 相似文献
36.
37.
38.
Ye Gao Lei Xin Yu-Xin Wang Yuan-Hang Dong Zhuan Liao 《Scandinavian journal of gastroenterology》2020,55(1):105-113
AbstractBackground and aim: Capsule retention is the most common adverse event associated with video capsule endoscopy. The use of double-balloon enteroscopy-assisted capsule endoscope retrieval has been increasingly reported in recent years. However, evidence is limited regarding its success rate, associated factors, and subsequent clinical outcomes.Methods: A systematic review of relevant studies published before January 2019 was performed. Successful retrieval rate and associated factors, rate of endoscopic balloon dilation, and outcomes after double-balloon enteroscopy were summarized and pooled.Results: Within 154 associated original articles, 12 including 150 cases of capsule retrieval by double-balloon enteroscopy were included. The estimated pooled successful retrieval rate was 86.5% (95% confidence interval, 75.6–95.1%). Anterograde approach and capsules retained in the jejunum or trapped by malignant strictures were associated with a higher successful retrieval rate than the retrograde approach (62/83 [74.7%] vs. 10/38 [26.3%], p?<?.001) and capsules retained in the ileum (41/41 [100.0%] vs. 43/58 [74.1%], p?<?.001) or trapped by benign strictures (21/21 [100.0%] vs. 65/83 [78.3%], p?=?.043). Endoscopic balloon dilation was performed in 38.8% (95% confidence interval, 22.3–56.3%) of patients with benign strictures. Two perforations (1.3%) were reported as severe adverse events after double-balloon enteroscopy. A significantly lower surgery rate was found among cases with successful video capsule removal compared with unsuccessful cases (7.2% vs. 38.5%, p?=?.002).Conclusions: Double-balloon enteroscopy is feasible and safe for removing retained video capsule endoscopes, and its use could decrease the need for surgery in patients with benign strictures and facilitate subsequent surgery in patients with malignant strictures. 相似文献
39.